Caspersen Carl J, Thomas G Darlene, Beckles Gloria L A, Bullard Kai McKeever
Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia.
Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia.
Am J Prev Med. 2015 Mar;48(3):253-63. doi: 10.1016/j.amepre.2014.10.004. Epub 2015 Jan 15.
Sex-specific prediabetes estimates are not available for older-adult Americans.
To estimate prediabetes prevalence, using nationally representative data, in civilian, non-institutionalized, older U.S. adults.
Data from 7,995 participants aged ≥50 years from the 1999-2010 National Health and Nutrition Examination Surveys were analyzed in 2013. Prediabetes was defined as hemoglobin A1c=5.7%-6.4% (39-47 mmol/mol [HbA1c5.7]), fasting plasma glucose of 100-125 mg/dL (impaired fasting glucose [IFG]), or both. Crude and age-adjusted prevalences for prediabetes, HbA1c5.7, and IFG by sex and three age groups were calculated, with additional adjustment for sex, age, race/ethnicity, poverty status, education, living alone, and BMI.
From 1999 to 2005 and 2006 to 2010, prediabetes increased for adults aged 50-64 years (38.5% [95% CI=35.3, 41.8] to 45.9% [42.3, 49.5], p=0.003) and 65-74 years (41.3% [37.2, 45.5] to 47.9% [44.5, 51.3]; p=0.016), but not significantly for adults aged ≥75 years (45.1% [95% CI=41.1, 49.1] to 48.9% [95% CI=45.2, 52.6]; p>0.05). Prediabetes increased significantly for women in the two youngest age groups, and HbA1c5.7 for both sexes (except men aged ≥75 years), but IFG remained stable for both sexes. Men had higher prevalences than women for prediabetes and IFG among adults aged 50-64 years, and for IFG among adults aged ≥75 years. Across demographic subgroups, adjusted prevalence gains for both sexes were similar and most pronounced for HbA1c5.7, virtually absent for IFG, but greater for women than men for prediabetes.
Given the large, growing prediabetes prevalence and its anticipated burden, older adults, especially women, are likely intervention targets.
尚无针对美国老年成年人的特定性别糖尿病前期估计数据。
利用具有全国代表性的数据,估计美国非机构化老年平民成年人的糖尿病前期患病率。
2013年分析了1999 - 2010年国家健康和营养检查调查中7995名年龄≥50岁参与者的数据。糖尿病前期定义为糖化血红蛋白A1c = 5.7% - 6.4%(39 - 47 mmol/mol [HbA1c5.7])、空腹血糖100 - 125 mg/dL(空腹血糖受损[IFG])或两者兼具。计算了按性别和三个年龄组划分的糖尿病前期、HbA1c5.7和IFG的粗患病率及年龄调整患病率,并对性别、年龄、种族/族裔、贫困状况、教育程度、独居情况和体重指数进行了额外调整。
从1999年至2005年以及2006年至2010年,50 - 64岁成年人的糖尿病前期患病率上升(从38.5% [95%置信区间=35.3, 41.8]升至45.9% [42.3, 49.5],p = 0.003),65 - 74岁成年人的患病率也上升(从41.3% [37.2, 45.5]升至47.9% [44.5, 51.3];p = 0.016),但75岁及以上成年人的患病率无显著上升(从45.1% [95%置信区间=41.1, 49.1]升至48.9% [95%置信区间=45.2, 52.6];p>0.05)。两个最年轻年龄组的女性糖尿病前期患病率显著上升,男女两性的HbA1c5.7患病率均上升(75岁及以上男性除外),但两性的IFG患病率保持稳定。在50 - 64岁成年人中,男性的糖尿病前期和IFG患病率高于女性,在75岁及以上成年人中,男性的IFG患病率高于女性。在各人口亚组中,两性的调整患病率增幅相似,HbA1c5.7的增幅最为明显,IFG几乎无增幅,而糖尿病前期女性的增幅大于男性。
鉴于糖尿病前期患病率庞大且不断上升及其预期负担,老年人,尤其是女性,可能是干预目标人群。